XNAS
ASTC
Market cap15mUSD
Jul 09, Last price
9.48USD
1D
4.06%
1Q
179.65%
Jan 2017
-95.79%
Name
Astrotech Corp
Chart & Performance
P/E
—
P/S
15.16
EPS
—
Div Yield, %
—
Shrs. gr., 5y
51.08%
Rev. gr., 5y
16.54%
Revenues
1m
-36.96%
Net income
-14m
L+18.72%
CFO
-13m
L+33.18%
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Astrotech Corporation is an international company focused on developing and bringing to market scientific and technological advancements. Its operations are structured into three distinct segments: Astrotech Technologies, Inc. (ATI), 1st Detect Corporation (1st Detect), and AgLAB Inc (AgLAB). ATI is responsible for holding the intellectual property rights to and licensing its proprietary AMS Technology, which serves as its foundational mass spectrometry platform. The 1st Detect division manufactures sophisticated trace detectors for identifying explosives and narcotics. Its key offering, the TRACER 1000, is an advanced mass spectrometer designed to supersede existing explosives detection equipment in high-security environments such as airports, cargo facilities, and border crossings. AgLAB's focus includes the development of the AgLAB-1000, a mass spectrometer tailored for applications within the hemp and cannabis sectors. Additionally, this segment is creating the BreathTest-1000, an analytical tool intended for screening volatile organic compound metabolites in breath samples. Originally established in 1984 under the name SPACEHAB, Inc., the company officially rebranded as Astrotech Corporation in 2009. Its corporate headquarters are situated in Austin, Texas.
Valuation
Title USD in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||